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Background: General and regional anesthesia are the two main techniques used in cesarean section. Regional
anesthesia is preferred, but under certain circumstances, such as by patient request and in patients with back
deformities, general anesthesia is the only option. Commonly used induction agents include thiopental, ketamine,
and propofol, depending on availability and the maternal clinical condition. The objective of this study was to
investigate the effects of thiopental and propofol on the neonatal Apgar score and maternal recovery time
following emergency cesarean section in order to determine the superior agent for mothers and neonates.
Methods: This single-blinded randomized clinical trial included 150 ASA I and II patients block-randomized equally
between the two study arms. Pregnant women at term scheduled to undergo cesarean section and their neonates
were enrolled. The primary outcomes were the Apgar scores through 10-min postpartum, resuscitation requirement,
and admission to the neonatal intensive care unit. The secondary outcome was the maternal recovery times.
Results: At 0 min (umbilical cord clamp time), 43 (57.3%) neonates in the propofol group had an Apgar score < 7
compared with 31 (41.3%) neonates in the thiopental group (p = 0.05). The maternal recovery time was shorter in
the propofol group than in the thiopental group (25 min vs. 31 min, respectively, p = 0.003).
Conclusion: Apgar scores do not differ significantly whether thiopental or propofol is used for anesthetic induction
in women undergoing general anesthesia for an emergency cesarean section.
Trial registration: Pan-African Clinical Trial Registry (#PACTR201306000536344) http://www.pactr.org/ATMWeb/
appmanager/atm/atmregistry?_nfpb=true&_pageLabel=atm_portal_page_mytrials
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Regional anesthesia is generally preferred during cesarean
section, but general anesthesia may be the only option
under certain circumstances such as patient preference,
back deformities not amenable to spinal anesthesia, failed
spinal anesthesia, intracranial hypertension, maternal co-
agulopathy, and certain neurologic diseases [1]. A safe in-
duction agent for obstetrics should, among other things,
provide a smooth, quick induction, maintain maternal
hemodynamic function, and exert minimal to no effect on* Correspondence: janattumukunde@gmail.com
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unless otherwise stated.the Apgar score. Thiopental has been routinely used as an
anesthetic induction agent for cesarean section since the
1930s and is the standard against which all new agents are
compared. However, it has several disadvantages, includ-
ing decreased maternal arterial pressure, which, when
coupled with a long induction time, can reduce the Apgar
score [2]. Propofol is widely used for induction and main-
tenance of anesthesia in other surgeries but not in obstet-
ric procedures. It has a short induction time and blunts
airway reflexes during laryngoscopy; compared with thio-
pental, patients emerge faster from propofol anesthesia
[3]. However, propofol also crosses the placenta [4,5] andntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ing in a low Apgar score at birth [6,7].
The population of pregnant mothers requiring cesarean
section either by default or by request is rising, [8] and the
lack of skilled labor in Uganda is a constant problem [9].
Maternal and child health is the focus of millennial devel-
opment goals 4 and 5, and improving safety and reducing
maternal and neonatal mortality are necessary to achieve
these goals. Therefore, the objective of this study was to
investigate the effects of thiopental and propofol on the
neonatal Apgar score and maternal recovery time follow-
ing cesarean section.
Methods
Study design and setting
This randomized single-blinded clinical trial was performed
at Mulago Hospital, which is the main national referral hos-
pital in Uganda. Its obstetric department receives mothers
from Kampala and the surrounding region. Approximately
30,000 deliveries are performed annually and 600 cesarean
sections monthly, of which 15% are performed under
general anesthesia. The high rate of general anesthesia
for cesarean sections is due to the erratic availability of
spinal needles and drugs, and unfounded patient fears
over lumbar punctures in general. Anesthesia is performed
by anesthesiologists, anesthetic officers, or postgraduate
students in anesthesia.
Study population
We included ASA class I and II term pregnant mothers
scheduled to receive general anesthesia for an emergency
cesarean section and excluded all patients potentially al-
lergic to propofol or thiopental.
Randomization, blinding, and enrollment
Participants were block randomized into the two study
arms. An independent statistician randomly generated
the sequence of participant allocation to the thiopental
or propofol treatment groups. First, random blocks of
4–10 participants were generated, and within each block,
a random sequence for the participant intervention groups
was generated and labeled either 1 (one) for propofol or 2
(two) for thiopental. This sequence was concealed from
all participants by inserting it into opaque, sequentially
arranged sealed envelopes. The intervention group allo-
cations were placed in small envelopes that were then
placed in bigger envelopes representing the blocks. At
the time of participant recruitment, the study investiga-
tor retrieved the next available small envelope, which
indicated the intervention group, from the next avail-
able block envelope and handed it to the participant.
The patient, midwife, and pediatrician were blinded to
the group assignment, but the anesthesia provider was
not. The anesthesia providers were either qualifiedanesthesiologists or residents in their final year of resi-
dency. After screening for inclusion and exclusion criteria,
eligible women were consecutively enrolled in the study.Sample size
This was a non-inferiority study. To determine whether
a 20% difference in the Apgar score existed between thio-
pental and propofol treatment, 150 patients were required
to be 90% certain that the upper limit of a one-sided 95%
confidence interval (or a 90% two-sided interval) excluded
a greater than 20% difference in favor of the standard
(thiopental) group.Intervention and anesthetic technique
Each patient was wheeled into the surgical suite in a left
lateral position and transferred to the operating table,
and a wedge was placed under the right hip to achieve a
leftward uterine displacement of 15°. Routine monitors
were attached (pulse oximeter for heart rate and oxygen
saturation, continuous ECG monitor, and automatic blood
pressure monitor). A wide-bore intravenous cannula
(16- or 18-G) was placed in the less dominant forearm
for administration of drugs and fluids. Intravenous meto-
clopramide (10 mg) and ranitidine (50 mg) diluted in
20 ml of saline was administered over 2 min. The surgical
site was then scrubbed and draped aseptically by the
surgeon. Denitrogenification with 100% oxygen was per-
formed for 3 min, and lignocaine (1–2 mg/kg) was admin-
istered to blunt the laryngeal reflexes and numb the
catheterized vein to the nociceptive effects of the induc-
tion drugs. The induction agent was administered, either
propofol (2 mg/kg) or thiopentone (4 mg/kg) depending
on which study arm the patient was enrolled in, cricoid
pressure was applied, and suxamethonium (1.5 mg/kg)
administered. Using a laryngoscope, tracheal intubation
was performed, confirmed, and secured within 2 min.
The patient was maintained on isoflurane (1–1.5%)
mixed with 100% oxygen flowing at 2.5 L/min until the
start of skin closure. Nitrous oxide and ambient air
were not used as these agents are unavailable at this
hospital.
Oxytocin (5 IU) diluted in 5 ml of saline was adminis-
tered as a slow bolus after delivering the baby’s shoulders.
Pain was controlled by administering 0.1 mg/kg of mor-
phine after the baby’s umbilical cord was clamped. Rectal
paracetamol was also administered at the end of the
procedure. All patients received 1,500 ml of crystalloids
(normal saline or lactated Ringer’s solution). If hypotension,
which was defined as a 20% reduction from the baseline
blood pressure, was encountered, then additional crystal-
loids and vasopressors were administered at the discretion
of the anesthesia provider.
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The neonatal Apgar score was assessed and recorded at
0, 1, 5, and 10 min after the umbilical cord was clamped
by the midwife. The requirement for resuscitation and
admission into the neonatal special care unit (NICU) was
also recorded by the study assistant. Criteria for NICU ad-
mission was any neonate requiring more than 3 min of
continuous bag mask ventilation during resuscitation as
per NICU protocols.Secondary outcomes
The maternal recovery time was measured, defined as
the duration from induction to complete orientation in
time, place, and person.Data management
All data were double entered into Epidata version 3.1
software, with range, consistency, and validation checks
embedded to aid data cleaning. The data were analyzed
using Stata version 12 software.
Categorical data, including the number of participants
and the respective proportions, are presented in tabular,
graphical and text forms, and categorized into propofol
and thiopental groups. The two groups were compared
using the Chi square test. Continuous data are presented
as the mean with standard deviation, and were compared
between the groups using the t-test to detect any signifi-
cant differences. The median and interquartile range of
the decision-to-delivery interval was calculated, and the
differences between the groups were determined using
non-parametric testing. A p-value of < 0.05 indicated stat-
istical significance.
An intention-to-treat analysis method was used, and
the main outcome of interest was an Apgar score of less
than 7. The Poisson regression model was used to assess
the incidence risk of the outcome between the two
randomization groups and to estimate the risk ratio and
confidence interval. Baseline characteristics were equally
distributed between the randomization groups, and
none of the outcomes differed significantly between the
randomization groups. Therefore, multivariate analysis
for potential confounders was not performed.Data safety management board
The Data Safety Management Board (DSMB) comprised
an anesthesiologist, statistician, obstetrician, and a pharma-
cist who were informed if an adverse event occurred. The
study would be discontinued if 10% of study subjects in
one study arm experienced an adverse event associated
with the study drugs as determined by the DSMB, or if a p
value of <0.025 was obtained on an interim analysis per-
formed 3 months after beginning the study.Ethical considerations
This study was approved by the Department of
Anesthesiology, Mulago Hospital Ethics Committee,
the School of Medicine Research and Ethics Committee
(SOMREC), and the Department of Obstetrics and
Gynecology. All patients provided informed, written consent
before the start of surgery. This trial is registered in the Pan-
African Clinical Trial Registry (#PACTR201306000536344).
Results
A total 150 pregnant women were enrolled from
November 2013 to April 2014 as shown in Figure 1.
Maternal baseline characteristics
Maternal baseline characteristics were equally distrib-
uted between the two study groups. The mean maternal
age in the propofol and thiopental groups was 25.2 years
and 24.2 years, and the mean weight was 68.6 kg and
66.7 kg, respectively. The median overall decision-to-
delivery interval was 137.5 (IQR 20–968), and there was
no statistically significant difference between the median
intervals in the propofol (median 145; IQR 20–600) and
thiopental (median 120; IQR 26–900; p = 0.540) groups.
The induction-to-delivery interval and the surgical dur-
ation also showed no significant differences between the
groups (Table 1).
Apgar score distribution
A total 74 neonates had an Apgar score < 7. Of those, 43
were in the propofol group and 31 in the thiopental group,
with an incidence ratio of 1.42 (95% CI = 0.88–2.32) and a
p-value of 0.068.
At 0 min, 43 (57.3%) neonates in the propofol group
had an Apgar score < 7, compared with 31 (41.3%) neo-
nates in the thiopental group. At 1 min, 35 (46.7%) and
24 (32%) neonates had an Apgar score <7 in the propofol
and thiopental groups, respectively. At the 5-min mark,
13 (17.3%) and 8 (10.7%) neonates had Apgar scores < 7 in
the propofol and thiopental groups, respectively, while at
the 10-min mark, 3 (4%) neonates in the propofol group
and 2 (2.7%) in the thiopental group had an Apgar
score < 7.
The incidence of neonates with an Apgar score < 7 at
each interval is summarized in Table 2. There were no
statistically significant differences at any of the time points,
except at time 0, which had a marginally significant differ-
ence (p = 0.05). The proportion of neonates with an Apgar
score < 7 gradually decreased and did not differ signifi-
cantly between the groups at 10 min. The trends are
further detailed in Figure 2.
Neonatal intervention and NICU admission
Maneuvers to improve Apgar scores included gentle stimu-
lation or active resuscitation, which could be brief or
Figure 1 Summary of patient recruitment and allocation.
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Apgar score < 7 required gentle stimulation to raise the
Apgar score > 7. Of these, seven were in the propofol
group and seven in the thiopental group. The remaining
60 neonates required active resuscitation including stimu-
lation, bag mask ventilation, Laryngeal Mask Airway or
endotracheal tube insertion, and ventilation, which was
discontinued once the neonate demonstrated adequate
spontaneous respiration. A total 19 (52.8%) neonates with
an Apgar score ≤ 7 recovered (improved Apgar scores)
after < 5 min of resuscitation in the propofol group
compared with 12 (50%) neonates in the thiopental
group. Additionally, 1 (2.78%) neonate in the propofol
group and 2 (8.33%) in the thiopental group died. As
per protocol, any neonates with low Apgar scores who
required continuous bag mask ventilation for >3 min
were admitted for close observation for at least
24 hours.Table 1 Maternal baseline characteristics
Variable Overall
Maternal age 24.67 (5.64)
Maternal weight 67.61 (9.51)
Decision-to-delivery interval (min) 212.52 (218.45
Induction-to-cord clamping interval (min) 8.52 (4.48)
Surgical duration (min) 38.7 (13.4)
Data are presented as the mean (standard deviation).A total 22 neonates were admitted into the NICU for
close observation, comprising 16 (21.33%) neonates from
the propofol group and 6 (8%) from the thiopental
group. Of these, 2 (13.3%) neonates in the propofol
group continued to have an Apgar score < 7 (Table 3).
Maternal recovery time
The mean recovery time was significantly shorter in the
propofol group (25.1 min) than in the thiopental group
(31.4 min; p = 0.003).
Discussion
We conducted a single blinded randomized clinical trial
comparing the effects of propofol and thiopental on neo-
natal Apgar scores and maternal peri-operative outcomes.
The Apgar scores of neonates randomized into the two
study arms did not significantly differ, except at 0 min,
which showed a marginally significant difference. However,Propofol group Thiopental group
25.16 (5.11) 24.17 (6.11)
68.56 (9.31) 66.67 (9.68)
) 220.99 (213.04) 204.05 (224.84)
8.92 (5.01) 8.12 (4.47)
38.9 (12.5) 38.1 (14.9)
Table 2 Percentage of neonates with an Apgar score < 7 post-cesarean section
Apgar score Propofol group Thiopental group % difference (95% CI) p-value
0 min 43 (57.33) 31 (41.33) 16.00 (0.2–31.80) 0.050
1 min 35 (46.67) 24 (32) 14.67 (-0.7–30.12) 0.066
5 min 13 (17.33) 8 (10.67) 6.67 (-4.39–17.72) 0.239
10 min 3 (4) 2 (2.67) 1.33 (-4.41–7.07) 0.649
Data are presented as the number (percentage) of patients. CI, confidence interval.
Table 3 Neonatal resuscitation
Variable Propofol Thiopental Overall p value
Active resuscitation
No 39 (52.00) 51 (68.00) 90 (60.00)
Yes 36 (48.00) 24 (32.00) 60 (40.00) 0.046
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was greater than 50% in the propofol group (57.3%) com-
pared with that in the thiopental group (41.3%). While this
may not be statistically significant, this outcome cannot be
ignored because it highlights the need for skilled labor to
attend all births when anesthesia is induced with propofol.
The high prevalence of unsatisfactory Apgar scores can be
attributed to the high rate of placental transfer of propofol
coupled with the rapid loss of consciousness, as reported
in previous studies [5,10].
The percentage of neonates with an Apgar score < 7 at
the 1, 5, and 10-min intervals steadily decreased in both
study groups to nearly equal numbers of three and two
neonates in the propofol and thiopental groups, respect-
ively (Figure 2). None of the differences in the Apgar
scores were significant between the two groups, except
at 0 min, which showed borderline significance, despite
the Apgar scores being higher in the propofol group than
in the thiopental group (Table 2). This finding is consist-
ent with those of other studies comparing these two in-
duction agents [11-13]. The faster improvement in the
Apgar scores in the propofol group is probably caused by
the fast redistribution half-life of propofol, which is as low
as 1 min [14-16], while thiopental requires up to 6 min
[17]. This also explains the higher percentage of neonates
who recovered in <5 min in the propofol group.
An important finding in our study was the significantly
higher rate of NICU admissions in the propofol group
compared with the thiopental group. All but three neo-
nates admitted to the NICU survived at 24 hours.Figure 2 Percentage of neonates with a postpartum Apgar score < 7.The three neonates that died in this study had low
Apgar scores coupled with poor respiratory effort; they
required ventilator assistance, but because these services
were unavailable in the NICU, they died. A large percent-
age of neonates were admitted into the NICU (22% overall)
not only because of low Apgar scores, but also due to
protocol. All neonates with low Apgar scores requiring
continuous bag mask ventilation for >3 min are admit-
ted for close observation for at least 24 hours.
The mean recovery times were significantly shorter in
the propofol group than in the thiopental group at 25 min
(10.13) versus 31 min (14.66), respectively (p = 0.003).
Because the mean duration of isoflurane exposure was
identical in the groups (38.9 vs. 38.1 min), the prolonged
recovery time in the thiopental group can be solely attrib-
uted to the induction agent. Contribution from the initial
maternal physiologic state cannot be discounted; however,
under normal circumstances, this factor should be evenly
distributed between the two study groups as the study
population was randomized.
Our study had a number of limitations. This was a
single-blinded study because of the consistency of the
drugs evaluated; propofol is a white, milky suspension,Time to recovery (min)a
<5 19 (52.78) 12 (50.00) 31 (51.67)
5–10 14 (38.89) 10 (41.67) 24 (40.00)
Died 1 (2.78) 2 (8.33) 3 (5.00)
Apgar score < 7 2 (5.56) 0 2 (3.33) 0.518
NICU admission
No 59 (78.67) 69 (92.00) 128 (85.33)
Yes 16 (21.33) 6 (8.00) 22 (14.67) 0.021
Apgar score at admissionb
<7 2 (13.33) 0 2 (0.09)
≥7 14 (86.67) 6 (100) 20 (95.45) 0.531
Data presented as the number (percentage) of neonates.
aMeasured only in neonates who were resuscitated.
bMeasured only in neonates admitted to the neonatal intensive care unit (NICU).
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providers are aware of this difference; therefore, blinding
them is impossible. Any individual variation in the me-
tabolism of the induction drugs could not be measured;
thus, this potential contribution to the low Apgar scores
could not be accounted for. Finally, the interval between
the decision to perform cesarean section and the deliv-
ery was significantly higher than the recommended
30 min for an emergency case, which also contributed to
the low Apgar scores overall.
Conclusions
In conclusion, the Apgar scores did not differ significantly
whether thiopental or propofol was used as an induction
agent in women receiving general anesthetic for an emer-
gency cesarean section. However, there was a higher rate
of NICU admission among neonates in the propofol
group. Propofol does offer the advantage of a shorter
recovery time. In a referral center where cesarean sec-
tions under general anesthesia are inevitable whether
by design or default, it is important to carefully select
the induction agent. Furthermore, skilled personnel are
required to attend to neonates delivered by cesarean
section under general anesthesia.
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